On May 14, 2018, Hansoh’s Oulanning (Olanzapine Tablets) (available in 5mg and 10mg) was approved by National Medical Products Administration and passed the quality and efficacy consistency evaluation of generic drugs. We are the first in China to pass the consistency evaluation of Olanzapine Tablets.

Olanzapine is an atypical CNS disease drug mainly indicated for the treatment of schizophrenia, mania and bipolar affective disorder, and can be prescribed for long-term basis.